Breastfeeding in patients with peripartum cardiomyopathy: clinical outcomes and physician counseling.


Journal

International breastfeeding journal
ISSN: 1746-4358
Titre abrégé: Int Breastfeed J
Pays: England
ID NLM: 101251562

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 18 03 2024
accepted: 12 09 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Peripartum cardiomyopathy (PPCM) is a form of heart failure occurring towards the end of pregnancy or in the months following delivery. Concerns regarding the role of prolactin (the polypeptide hormone responsible for lactation) driving the pathogenesis of PPCM have led experts to discourage patients from breastfeeding; however, limited clinical data exist. We sought to (1) determine whether lactation was associated with less cardiac recovery and (2) assess the counseling about breastfeeding given to patients at the time of their initial diagnosis. Patients diagnosed with PPCM from 1999 to 2019 were identified through detailed chart review and demographic characteristics, comorbidities, outcomes, and lactation status were collected. Cardiac recovery was defined as left ventricular ejection fraction (LVEF) 55% or higher. A survey about breastfeeding and patient experience was administered by mail. Patients were only included in this analysis if definitive information about lactation status was documented. Of 220 patients with confirmed PPCM, lactation status was known definitively in 54 patients; of these, 18 (33%) had breastfed for at least 6 weeks and 36 (67%) did not breastfeed. There were no significant differences in the breastfeeding and non-breastfeeding groups related to baseline LVEF, age, race, gestational diabetes, smoking, hypertensive disorders of pregnancy, and medication treatments. Despite similar baseline LVEF at the time of diagnosis, there was no statistically significant difference in cardiac recovery based on lactation status. In a subset of patients with severe cardiac dysfunction at the time of diagnosis, there remained no significant differences in recovery based on lactation status. Of the 34 survey respondents, 62% were told not to breastfeed due to their diagnosis or concerns regarding safety of medications, and none were encouraged to breastfeed. In this retrospective cohort, lactation was not associated with lower rates of myocardial recovery. Importantly, a majority of patients had received counseling that they should not breastfeed. Future studies of the role of lactation in PPCM are needed in order to better understand the impact of breastfeeding and improve patient counseling.

Sections du résumé

BACKGROUND BACKGROUND
Peripartum cardiomyopathy (PPCM) is a form of heart failure occurring towards the end of pregnancy or in the months following delivery. Concerns regarding the role of prolactin (the polypeptide hormone responsible for lactation) driving the pathogenesis of PPCM have led experts to discourage patients from breastfeeding; however, limited clinical data exist. We sought to (1) determine whether lactation was associated with less cardiac recovery and (2) assess the counseling about breastfeeding given to patients at the time of their initial diagnosis.
METHODS METHODS
Patients diagnosed with PPCM from 1999 to 2019 were identified through detailed chart review and demographic characteristics, comorbidities, outcomes, and lactation status were collected. Cardiac recovery was defined as left ventricular ejection fraction (LVEF) 55% or higher. A survey about breastfeeding and patient experience was administered by mail. Patients were only included in this analysis if definitive information about lactation status was documented.
RESULTS RESULTS
Of 220 patients with confirmed PPCM, lactation status was known definitively in 54 patients; of these, 18 (33%) had breastfed for at least 6 weeks and 36 (67%) did not breastfeed. There were no significant differences in the breastfeeding and non-breastfeeding groups related to baseline LVEF, age, race, gestational diabetes, smoking, hypertensive disorders of pregnancy, and medication treatments. Despite similar baseline LVEF at the time of diagnosis, there was no statistically significant difference in cardiac recovery based on lactation status. In a subset of patients with severe cardiac dysfunction at the time of diagnosis, there remained no significant differences in recovery based on lactation status. Of the 34 survey respondents, 62% were told not to breastfeed due to their diagnosis or concerns regarding safety of medications, and none were encouraged to breastfeed.
CONCLUSION CONCLUSIONS
In this retrospective cohort, lactation was not associated with lower rates of myocardial recovery. Importantly, a majority of patients had received counseling that they should not breastfeed. Future studies of the role of lactation in PPCM are needed in order to better understand the impact of breastfeeding and improve patient counseling.

Identifiants

pubmed: 39472928
doi: 10.1186/s13006-024-00673-6
pii: 10.1186/s13006-024-00673-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

73

Informations de copyright

© 2024. The Author(s).

Références

Pediatrics. 2001 Sep;108(3):776-89
pubmed: 11533352
J Am Coll Cardiol. 2020 Jan 21;75(2):207-221
pubmed: 31948651
Curr Opin Cardiol. 2023 May 1;38(3):266-274
pubmed: 37016996
J Am Coll Cardiol. 2019 Feb 5;73(4):457-476
pubmed: 30704579
JACC Basic Transl Sci. 2019 Jun 24;4(3):291-300
pubmed: 31312753
Eur J Heart Fail. 2010 Aug;12(8):767-78
pubmed: 20675664
Cell. 2007 Feb 9;128(3):589-600
pubmed: 17289576
Eur Heart J. 2018 Sep 7;39(34):3165-3241
pubmed: 30165544
J Biomed Inform. 2015 Jun;55:290-300
pubmed: 25979153

Auteurs

Angelina Noll (A)

Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Kris R Kawamoto (KR)

Cardiovascular Diseases, Queen's University Medical Group, Honolulu, HI, USA.

Maya T Dassanayake (MT)

Department of Medicine, Division of Cardiology, University of South Carolina-Greenville, Greenville, SC, USA.

Laura Leuenberger (L)

Department of Medicine, Division of Pulmonary, Critical Care and Sleep, Ohio State University, Columbus, OH, USA.

Stephanie M Spehar (SM)

Department of Medicine, Division of Cardiovascular Medicine, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA.

Jenny Wu (J)

Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Elizabeth Langen (E)

Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI, 48105, USA.

Melinda B Davis (MB)

Department of Medicine, Division of Cardiovascular Medicine, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA. davismb@umich.edu.
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI, 48105, USA. davismb@umich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH